Brain Imaging of Multiple Sclerosis: the Next 10 Years

Young, 1981, Nuclear magnetic resonance imaging of the brain in multiple sclerosis, Lancet, 2, 1063, 10.1016/S0140-6736(81)91273-3 McDonald, 2001, Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis, Ann Neurol, 50, 121, 10.1002/ana.1032 Miller, 2004, Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis, Ann Neurol, 56, 273, 10.1002/ana.20156 Korteweg, 2005, How to use spinal cord magnetic resonance imaging in the McDonald diagnostic criteria for multiple sclerosis, Ann Neurol, 57, 606, 10.1002/ana.20412 Polman, 2005, Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.”, Ann Neurol, 58, 840, 10.1002/ana.20703 Caramanos, 2007, Axonal pathology in patients with multiple sclerosis: evidence from in vivo proton magnetic resonance spectroscopy Bo, 2004, Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis, Neuropathol Appl Neurobiol, 30, 106, 10.1111/j.1365-2990.2003.00521.x Lycklama a Nijeholt, 2003, Differences between subgroups of MS: MRI findings and correlation with histopathology, J Neurol Sci, 206, 173, 10.1016/S0022-510X(02)00336-2 Smith, 1993, Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions, Ann Neurol, 33, 480, 10.1002/ana.410330511 Arnold, 2002, MRI in the diagnosis and management of multiple sclerosis, Neurology, 58, S23, 10.1212/WNL.58.8_suppl_4.S23 Fisniku, 2008, Gray matter atrophy is related to long-term disability in multiple sclerosis, Ann Neurol, 63, 247, 10.1002/ana.21423 Bakshi, 2008, MRI in multiple sclerosis: current status and future prospects, Lancet Neurol, 7, 615, 10.1016/S1474-4422(08)70137-6 Hickman, 2007, Optic nerve imaging in multiple sclerosis, J Neuroimaging, 17, 42S, 10.1111/j.1552-6569.2007.00136.x Wattjes, 2006, Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T, Eur Radiol, 16, 2067, 10.1007/s00330-006-0195-4 Kieseier, 2007, Treatment and treatment trials in multiple sclerosis, Curr Opin Neurol, 20, 286, 10.1097/WCO.0b013e3281568b80 Confavreux, 2006, Natural history of multiple sclerosis: a unifying concept, Brain, 129, 606, 10.1093/brain/awl007 Lucchinetti, 2000, Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination, Ann Neurol, 47, 707, 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q Pathak, 2003, Quantitative image analysis: software systems in drug development trials, Drug Discov Today, 8, 451, 10.1016/S1359-6446(03)02698-9 Pike, 2000, Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images, Radiology, 215, 824, 10.1148/radiology.215.3.r00jn02824 Wu, 2006, Automated segmentation of multiple sclerosis lesion subtypes with multichannel MRI, Neuroimage, 32, 1205, 10.1016/j.neuroimage.2006.04.211 Trusheim, 2007, Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers, Nat Rev Drug Discov, 6, 287, 10.1038/nrd2251 Booth, 2003, Quest for the best, Nat Rev Drug Discov, 2, 838, 10.1038/nrd1203 Fox, 2007, The immunogenicity of disease-modifying therapies for multiple sclerosis: clinical implications for neurologists, Neurologist, 13, 355, 10.1097/NRL.0b013e318148c08e Coles, 1999, Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis, Ann Neurol, 46, 296, 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-# Polman, 2006, A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis, N Engl J Med, 354, 899, 10.1056/NEJMoa044397 Liu, 2005, Multiple sclerosis medical image analysis and information management, J Neuroimaging, 15, 103S, 10.1177/1051228405282864 Bosnell, 2008, Reproducibility of fMRI in the clinical setting: implications for trial designs, Neuroimage, 10.1016/j.neuroimage.2008.05.005 Held, 2005, Predictors of relapse rate in MS clinical trials, Neurology, 65, 1769, 10.1212/01.wnl.0000187122.71735.1f Schach, 2007, Pooled historical MRI data as a basis for research in multiple sclerosis—a statistical evaluation, Mult Scler, 13, 509, 10.1177/1352458506069537 De Stefano, 2006, Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis, Ann Neurol, 59, 634, 10.1002/ana.20767 Ollier, 2005, UK Biobank: from concept to reality, Pharmacogenomics, 6, 639, 10.2217/14622416.6.6.639 Smith, 2002, Accurate, robust, and automated longitudinal and cross-sectional brain change analysis, Neuroimage, 17, 479, 10.1006/nimg.2002.1040 Stevenson, 2002, Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy, J Neurol, 249, 171, 10.1007/PL00007860 Smith, 2007, Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX, Neuroimage, 36, 1200, 10.1016/j.neuroimage.2007.04.035 Gottesman, 2003, The endophenotype concept in psychiatry: etymology and strategic intentions, Am J Psychiatry, 160, 636, 10.1176/appi.ajp.160.4.636 Zivadinov, 2007, Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor, Hum Mol Genet, 16, 2659, 10.1093/hmg/ddm189 van Veen, 2007, CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis, J Neuroimmunol, 190, 157, 10.1016/j.jneuroim.2007.08.005 Chanock, 2007, Replicating genotype-phenotype associations, Nature, 447, 655, 10.1038/447655a Meyer-Lindenberg, 2006, Intermediate phenotypes and genetic mechanisms of psychiatric disorders, Nat Rev Neurosci, 7, 818, 10.1038/nrn1993 Sturzebecher, 2003, Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis, Brain, 126, 1419, 10.1093/brain/awg147 Sibson, 2004, MRI detection of early endothelial activation in brain inflammation, Magn Reson Med, 51, 248, 10.1002/mrm.10723 Bulte, 2002, In vivo magnetic resonance tracking of magnetically labeled cells after transplantation, J Cereb Blood Flow Metab, 22, 899, 10.1097/00004647-200208000-00001 Trivedi, 2006, Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages, Arterioscler Thromb Vasc Biol, 26, 1601, 10.1161/01.ATV.0000222920.59760.df Trivedi, 2004, In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI, Stroke, 35, 1631, 10.1161/01.STR.0000131268.50418.b7 Bellin, 1998, Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles—initial clinical experience, Radiology, 207, 799, 10.1148/radiology.207.3.9609907 Dousset, 2006, MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium, AJNR Am J Neuroradiol, 27, 1000 Querol, 2006, Amplification strategies in MR imaging: activation and accumulation of sensing contrast agents (SCAs), J Magn Reson Imaging, 24, 971, 10.1002/jmri.20724 Ge, 2008, Seven-tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis, Arch Neurol, 65, 812, 10.1001/archneur.65.6.812 Olafsen, 2006, Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment, Nat Protoc, 1, 2048, 10.1038/nprot.2006.322 Arnold, 1990, Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease, Magn Reson Med, 14, 154, 10.1002/mrm.1910140115 Fu, 1998, Imaging axonal damage of normal-appearing white matter in multiple sclerosis, Brain, 121, 103, 10.1093/brain/121.1.103 De Stefano, 1998, Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study, Brain, 121, 1469, 10.1093/brain/121.8.1469 Matthews, 1998, Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis, Semin Neurol, 18, 327, 10.1055/s-2008-1040884 Ramnani, 2004, New approaches for exploring anatomical and functional connectivity in the human brain, Biol Psychiatry, 56, 613, 10.1016/j.biopsych.2004.02.004 Song, 2005, Demyelination increases radial diffusivity in corpus callosum of mouse brain, Neuroimage, 26, 132, 10.1016/j.neuroimage.2005.01.028 Song, 2003, Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia, Neuroimage, 20, 1714, 10.1016/j.neuroimage.2003.07.005 Zhu, 1999, Axonal cytoskeleton changes in experimental optic neuritis, Brain Res, 824, 204, 10.1016/S0006-8993(99)01191-9 Behrens, 2003, Characterization and propagation of uncertainty in diffusion-weighted MR imaging, Magn Reson Med, 50, 1077, 10.1002/mrm.10609 Wakana, 2004, Fiber tract-based atlas of human white matter anatomy, Radiology, 230, 77, 10.1148/radiol.2301021640 Catani, 2005, Perisylvian language networks of the human brain, Ann Neurol, 57, 8, 10.1002/ana.20319 Schmahmann, 2007, Cerebral white matter—historical evolution of facts and notions concerning the organization of the fiber pathways of the brain, J Hist Neurosci, 16, 237, 10.1080/09647040500495896 Tomassini, 2007, Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations, J Neurosci, 27, 10259, 10.1523/JNEUROSCI.2144-07.2007 Johansen-Berg, 2004, Changes in connectivity profiles define functionally distinct regions in human medial frontal cortex, Proc Natl Acad Sci U S A, 101, 13335, 10.1073/pnas.0403743101 Behrens, 2003, Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging, Nat Neurosci, 6, 750, 10.1038/nn1075 Smith, 2006, Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data, Neuroimage, 31, 1487, 10.1016/j.neuroimage.2006.02.024 Ciccarelli, 2006, Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis, Brain, 129, 1859, 10.1093/brain/awl100 Ciccarelli, 2005, Optic radiation changes after optic neuritis detected by tractography-based group mapping, Hum Brain Mapp, 25, 308, 10.1002/hbm.20101 Ciccarelli, 2008, Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics, Hum Brain Mapp Matthews, 1990, A proton magnetic resonance spectroscopy study of focal epilepsy in humans, Neurology, 40, 985, 10.1212/WNL.40.6.985 Moffett, 2007, N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology, Prog Neurobiol, 81, 89, 10.1016/j.pneurobio.2006.12.003 Dautry, 2000, Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid, J Cereb Blood Flow Metab, 20, 789, 10.1097/00004647-200005000-00005 Smith, 2002, The role of nitric oxide in multiple sclerosis, Lancet Neurol, 1, 232, 10.1016/S1474-4422(02)00102-3 De Stefano, 2001, Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability, Arch Neurol, 58, 65, 10.1001/archneur.58.1.65 Wylezinska, 2003, Thalamic neurodegeneration in relapsing-remitting multiple sclerosis, Neurology, 60, 1949, 10.1212/01.WNL.0000069464.22267.95 De Stefano, 1995, Reversible decreases in N-acetylaspartate after acute brain injury, Magn Reson Med, 34, 721, 10.1002/mrm.1910340511 Cader, 2007, Discordant white matter N-acetylaspartate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis, Neuroimage, 36, 19, 10.1016/j.neuroimage.2007.02.036 Narayanan, 2001, Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b, J Neurol, 248, 979, 10.1007/s004150170052 Kalra, 1998, Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy, Neuroreport, 9, 1757, 10.1097/00001756-199806010-00016 Parry, 2003, Beta-interferon treatment does not always slow the progression of axonal injury in multiple sclerosis, J Neurol, 250, 171, 10.1007/s00415-003-0965-8 Peterson, 2001, Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions, Ann Neurol, 50, 389, 10.1002/ana.1123 Wegner, 2006, Neocortical neuronal, synaptic, and glial loss in multiple sclerosis, Neurology, 67, 960, 10.1212/01.wnl.0000237551.26858.39 Pomeroy, 2005, Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis, Brain, 128, 2713, 10.1093/brain/awh626 Magliozzi, 2007, Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology, Brain, 130, 1089 Chen, 2004, Relating neocortical pathology to disability progression in multiple sclerosis using MRI, Neuroimage, 23, 1168, 10.1016/j.neuroimage.2004.07.046 Cifelli, 2002, Thalamic neurodegeneration in multiple sclerosis, Ann Neurol, 52, 650, 10.1002/ana.10326 Zhu, 2003, Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis, Am J Pathol, 162, 1639, 10.1016/S0002-9440(10)64298-8 Wegner, 2003, A new view of the cortex, new insights into multiple sclerosis, Brain, 126, 1719, 10.1093/brain/awg238 Bagnato, 2006, In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis, AJNR Am J Neuroradiol, 27, 2161 Bridge, 2005, Independent anatomical and functional measures of the V1/V2 boundary in human visual cortex, J Vis, 5, 93, 10.1167/5.2.1 Deoni, 2005, High-resolution T1 and T2 mapping of the brain in a clinically acceptable time with DESPOT1 and DESPOT2, Magn Reson Med, 53, 237, 10.1002/mrm.20314 Fischl, 1999, Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system, Neuroimage, 9, 195, 10.1006/nimg.1998.0396 Dale, 1999, Cortical surface-based analysis. I. Segmentation and surface reconstruction, Neuroimage, 9, 179, 10.1006/nimg.1998.0395 De Stefano, 2003, Evidence of early cortical atrophy in MS: relevance to white matter changes and disability, Neurology, 60, 1157, 10.1212/01.WNL.0000055926.69643.03 Sicotte, 2008, Regional hippocampal atrophy in multiple sclerosis, Brain, 131, 1134, 10.1093/brain/awn030 Wong, 1999, Quantitative perfusion imaging using arterial spin labeling, Neuroimaging Clin N Am, 9, 333 Rashid, 2004, Abnormalities of cerebral perfusion in multiple sclerosis, J Neurol Neurosurg Psychiatr, 75, 1288, 10.1136/jnnp.2003.026021 Wong, 2000, Arterial spin labeling with higher SNR and temporal resolution, Magn Reson Med, 44, 511, 10.1002/1522-2594(200010)44:4<511::AID-MRM2>3.0.CO;2-6 Luh, 1999, QUIPSS II with thin-slice TI1 periodic saturation: a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling, Magn Reson Med, 41, 1246, 10.1002/(SICI)1522-2594(199906)41:6<1246::AID-MRM22>3.0.CO;2-N Nestor, 2003, The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET, J Neurol Neurosurg Psychiatry, 74, 1521, 10.1136/jnnp.74.11.1521 Matthews, 2006, Applications of fMRI in translational medicine and clinical practice, Nat Rev Neurosci, 7, 732, 10.1038/nrn1929 Lee, 2000, The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis, Ann Neurol, 47, 606, 10.1002/1531-8249(200005)47:5<606::AID-ANA8>3.0.CO;2-L Reddy, 2000, Relating axonal injury to functional recovery in MS, Neurology, 54, 236, 10.1212/WNL.54.1.236 Reddy, 2000, Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis, Brain, 123, 2314, 10.1093/brain/123.11.2314 Rocca, 2005, Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes, Lancet Neurol, 4, 618, 10.1016/S1474-4422(05)70171-X Mainero, 2004, fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis, Neuroimage, 21, 858, 10.1016/j.neuroimage.2003.10.004 Logothetis, 2008, What we can do and what we cannot do with fMRI, Nature, 453, 869, 10.1038/nature06976 Cifelli, 2002, Cerebral plasticity in multiple sclerosis: insights from fMRI, Mult Scler, 8, 193, 10.1191/1352458502ms820oa Rocca, 2007, Functional MRI in multiple sclerosis, J Neuroimaging, 17, 36S, 10.1111/j.1552-6569.2007.00135.x Manson, 2008, Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition, Exp Brain Res, 187, 25, 10.1007/s00221-008-1276-1 Manson, 2006, Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy, Exp Brain Res, 174, 728, 10.1007/s00221-006-0517-4 Morgen, 2004, Training-dependent plasticity in patients with multiple sclerosis, Brain, 127, 2506, 10.1093/brain/awh266 Cader, 2006, Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis, Brain, 129, 527, 10.1093/brain/awh670 Agosta, 2008, Tactile-associated recruitment of the cervical cord is altered in patients with multiple sclerosis, Neuroimage, 39, 1542, 10.1016/j.neuroimage.2007.10.048 Matthews, 2004, Non-invasive mapping of brain functions and brain recovery: applying lessons from cognitive neuroscience to neurorehabilitation, Restor Neurol Neurosci, 22, 245 Johansen-Berg, 2002, Correlation between motor improvements and altered fMRI activity after rehabilitative therapy, Brain, 125, 2731, 10.1093/brain/awf282 Buchli, 2005, Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system, Annu Mediaev, 37, 556, 10.1080/07853890500407520 Martino, 2004, How the brain repairs itself: new therapeutic strategies in inflammatory and degenerative CNS disorders, Lancet Neurol, 3, 372, 10.1016/S1474-4422(04)00771-9 Saini, 2004, Altered cerebellar functional connectivity mediates potential adaptive plasticity in patients with multiple sclerosis, J Neurol Neurosurg Psychiatry, 75, 840, 10.1136/jnnp.2003.016782 Rocca, 2007, Altered functional and structural connectivities in patients with MS: a 3-T study, Neurology, 69, 2136, 10.1212/01.wnl.0000295504.92020.ca Wegner, 2008, Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study, Eur J Neurol, 15, 113, 10.1111/j.1468-1331.2007.02027.x Laule, 2007, Magnetic resonance imaging of myelin, Neurotherapeutics, 4, 460, 10.1016/j.nurt.2007.05.004 Laule, 2006, Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology, Mult Scler, 12, 747, 10.1177/1352458506070928 Laule, 2004, Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study, J Neurol, 251, 284, 10.1007/s00415-004-0306-6 McGowan, 1998, Magnetisation transfer imaging: theory and application to multiple sclerosis, J Neurol Neurosurg Psychiatry, 64, S66 Chen, 2008, Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions, Ann Neurol, 63, 254, 10.1002/ana.21302 Stankoff, 2006, Imaging of CNS myelin by positron-emission tomography, Proc Natl Acad Sci USA, 103, 9304, 10.1073/pnas.0600769103 Herholz, 2006, Cognitive dysfunction and emotional-behavioural changes in MS: the potential of positron emission tomography, J Neurol Sci, 245, 9, 10.1016/j.jns.2005.09.012 Bakshi, 1998, High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis, J Neuroimaging, 8, 228, 10.1111/jon199884228 Sorensen, 2006, The relationship between MRI and PET changes and cognitive disturbances in MS, J Neurol Sci, 245, 99, 10.1016/j.jns.2005.09.020 Blinkenberg, 1999, A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS, Neurology, 53, 149, 10.1212/WNL.53.1.149 Radu, 2007, Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis, Proc Natl Acad Sci U S A, 104, 1937, 10.1073/pnas.0610544104 Venneti, 2006, The peripheral benzodiazepine receptor (translocator protein 18kDa) in microglia: from pathology to imaging, Prog Neurobiol, 80, 308, 10.1016/j.pneurobio.2006.10.002 Vowinckel, 1997, PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis, J Neurosci Res, 50, 345, 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5 Banati, 2000, The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity, Brain, 123, 2321, 10.1093/brain/123.11.2321 Vas, 2008, Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients, J Neurol Sci, 264, 9, 10.1016/j.jns.2007.07.018 Fujita, 2008, Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation, Neuroimage, 40, 43, 10.1016/j.neuroimage.2007.11.011 Evangelou, 2001, Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis, Brain, 124, 1813, 10.1093/brain/124.9.1813 Dutta, 2006, Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients, Ann Neurol, 59, 478, 10.1002/ana.20736 Lingford-Hughes, 2002, Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography, J Cereb Blood Flow Metab, 22, 878, 10.1097/00004647-200207000-00013 Pike, 1993, Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites—current status, Nucl Med Biol, 20, 503, 10.1016/0969-8051(93)90082-6 Lendvai, 2008, Biodistribution of 68Ga-labeled LNA-DNA mixmer antisense oligonucleotides for rat chromogranin-A, Oligonucleotides, 18, 33, 10.1089/oli.2007.0104 Holt, 2003, Domain antibodies: proteins for therapy, Trends Biotechnol, 21, 484, 10.1016/j.tibtech.2003.08.007